News: Press Releases

2.25.2010
FOUGERA® ANNOUNCES FIRST GENERIC APPROVAL

5.7.2009
Fougera Says New Study on Generic Drug Savings Is Proof that Industry

2.13.2009
Fougera Employees Celebrate 160th Anniversary

9.12.2008
FDA APPROVES FOUGERA'S CLOTRIMAZOLE CREAM USP 1%

5.6.2008
FOUGERA FIRST-TO-MARKET WITH CALCIPOTRIENE TOPICAL SOLUTION 0.005% (Rx) (SCALP SOLUTION)

2.21.2008
NYCOMED US INC. ACQUIRES BRADLEY PHARMACEUTICALS, INC.

1.16.2007
Nycomed Officially Launched as Combined Group

11.17.2006
FOUGERA RECEIVES APPROVAL FOR FIRST GENERIC SULFACETAMIDE SODIUM TOPICAL SUSPENSION USP 10% (Rx)

6.6.2006
FOUGERA FIRST-TO-MARKET WITH METRONIDAZOLE TOPICAL GEL USP 0.75% (Rx)

5.24.2006
FOUGERA FIRST-TO-MARKET WITH METRONIDAZOLE LOTION 0.75% (RX)

9.30.2005
ALTANA INC ACQUIRES US DERMATOLOGY BUSINESS

9.16.2005
FOUGERA® RECEIVES FIRST TENTATIVE GENERIC APPROVAL FOR METROGEL®

9.13.2005
Fougera® Accelerates Availability of Emergency Care Products to Gulf States

8.9.2005
Fougera Marks Fifth Snakebite Season with CroFab® -

8.1.2005
FOUGERA UPGRADES WEB SITE FOR PHARMACISTS AND HEALTH PROFESSIONALS

7.13.2005
Fougera Extends Line with Introduction of Clotrimazole & Betamethasone Dipropionate Lotion Usp 1%/0.05% (base) (Rx)

5.12.2005
ALTANA Inc Inaugurates 100,000 Sq. Ft. Of Manufacturing Space In Hicksville, New York - Leading Pharmaceutical Manufacturer Cites Growth And Increased Demand For Topical Drugs Behind Expansion

4.11.2005
Fougera Announces Approval Of Mometasone Furoate Cream And Ointment (Rx)

1.19.2005
Fougera® Announces Diversification Of Crofab® Production

1.18.2005
Fougera® Aids In South Asia Disaster Relief; Topical Generic Manufacturer Provides Product And Cash Assistance To Tsunami Victims

1.18.2005
Fougera Introduces Two New Ophthalmics: Gentamicin Sulfate Ophthalmic Ointment USP (Sterile)(Rx) And Gentamicin Sulfate Ophthalmic Solution USP 0.3% (Sterile)(Rx)

1.3.2005
ALTANA Helps Flood Victims In South Asia

12.29.2004
Fougera Announces The First Approval Of Ciclopirox Olamine Cream USP (Rx)

12.16.2004
Fougera Announces The Approval Of Halobetasol Cream 0.05% (Rx) and Ointment 0.05% (Rx)